首页> 外国专利> METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS IN ONCOLOGICAL PATIENTS

METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS IN ONCOLOGICAL PATIENTS

机译:肿瘤患者术后并发症的预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention can be used to predict an adverse postoperative course with respect to postoperative purulent-septic complications, and also early postoperative progression of a tumour in the oncological patients. In the preoperative period, a relative peripheral blood content of lymphocyte CD3 + and CD 16 + subpopulations is evaluated, and a lymphocytic index is calculated by formula LI = [CD3+]-0.5[CD16+], where LI is a lymphocytic index; - [CD3+] and [CD16+] represent relative cell number of the corresponding lymphocyte subpopulations in a blood sample, in percentage. The value LI≤35 enables to predict high risk of development of postoperative purulent-septic complications and/or progression of tumour process.;EFFECT: at the preoperative stage, the method allows detecting a group of risk of development of purulent-septic complications.;1 tbl, 3 ex
机译:发明领域:本发明可用于预测与术后化脓性脓毒症并发症有关的不良术后病程,以及肿瘤患者术后的早期肿瘤进展。在术前评估淋巴细胞CD3 +和CD 16 +亚群的相对外周血含量,并通过公式LI = [CD3 +]-0.5 [CD16 +]计算淋巴细胞指数,其中LI是淋巴细胞指数; -[CD3 +]和[CD16 +]代表血液样本中相应淋巴细胞亚群的相对细胞数,以百分比表示。 LI≤35的值可以预测术后脓性脓毒症并发症和/或肿瘤进展的高风险。效果:在术前阶段,该方法可以检测出一群脓性脓毒症并发症的风险。 ; 1 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号